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CONGENITAL HEART DEFECTS AND THE NEED FOR BETTER 
TRANSITION MANAGEMENT 
DANIEL MARK FERRARI 
ABSTRACT 
	
Introduction 
Congenital Heart Defects are the most common congenital defects in the United States.  
They affect a significant proportion of all births, and many babies with CCHDs are not 
expected to survive their first year.  While diagnostic and surgical interventions have 
drastically improved mortality rates, a growing population of adolescent and adult CHD 
patients continue to face unique developmental, psychological and QoL issues. 
Methods 
Medical journal articles were utilized to determine the prevalence, mortality rates, 
survival rates, adverse psychological outcomes, and follow-up rates for CHD patients as 
they transitioned through adolescence.  Most articles came from Pediatrics, The Journal 
of Pediatrics, and Circulation. 
Results 
From 1980-2005, the prevalence of CHDs in the United States increased, while CHD 
mortality decreased by nearly half.  Over a similar time period, CHD patients were more 
likely to have poor psychological, behavioral, and QoL outcomes than their healthy 
peers.  Specifically, CHD patients were likely to have developmental disorders, lower 
QoL, and loss to follow-up when transitioning to adult care providers.  CHD patients also 
demonstrated a poor understanding of their condition, especially with respect to need for 
		 v 
follow-up, identifying symptoms of deteriorating heart condition, and the negative effects 
of smoking, drugs, and alcohol. 
Discussion 
Diagnostic and surgical interventions for CHD patients have led to increased survival.  
However, many of these interventions occur in the early stages of life, leaving a gap in 
medical management of CHD patients as they transition through adolescence.  This is 
represented by high attrition rates for those following-up with adult care providers, 
adverse psychosocial outcomes, and patients’ lack of knowledge about their condition. 
CHD patients may benefit from more comprehensive, coordinated and formal transition 
programs that incorporate good social support systems, self-efficacy, and education about 
their condition. 
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INTRODUCTION 
 
	 Congenital heart defects are structural abnormalities of the heart that exist at birth. 
These defects include abnormalities of the heart walls, heart valves, veins and arteries, 
and may lead to abnormal blood flow throughout the newborn.  While some CHDs 
resolve themselves without medical intervention, others lead to significant complications 
and may result in death.  Recent medical advances have increased the life expectancy for 
patients with CHD, as approximately 95% of babies born with a non-critical defect and 
69% of babies born with a critical defect are expected to survive to age 18 (“Data & 
Statistics”, 2015).  However, these patients still face many psychological, developmental, 
and social issues as they transition into adulthood. 
 In a normal heart, deoxygenated blood is collected in the right atrium and pumped 
to the lungs by the right ventricle, while oxygenated blood is collected in the left atrium 
and pumped to the rest of the body by the left ventricle.  CHD may compromise this 
process, leading to a lower volume of nutrient and oxygen rich blood circulating 
throughout the body, an overworked heart, and fluid build-up around the heart and lungs.  
Newborns may present with symptoms such as rapid breathing, fatigue, poor blood 
circulation, and cyanosis.  Furthermore, babies may have trouble gaining weight and 
developing properly due to tiredness when feeding.  These problems may be fatal for the 
newborn, especially in the first year (Oster et al., 2013).  
 Recent studies have revealed marked improvements in the 1-year and 18-year 
survival rates for patients with CHD.  Over the past few decades, diagnostic and surgical 
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advances have decreased CHD mortality by nearly half (Boneva et al., 2001).  Freedom 
et al. has highlighted the importance of diagnostic advances, as the emergence of fetal 
echocardiography, 3D imaging, and pulse oximetry have led to earlier detection of CHD, 
allowing quick intervention to limit the risks of ischemia (2000).  Improvements in TGA 
surgery, bypass surgery, and prostaglandin therapy have also led to increased oxygen 
circulation and better outcomes in complex CHD cases (Freedom et al., 2000).  With 
these successful interventions, the population of adults with CHD now outnumber the 
population of children with CHD (“Data & Statistics”, 2015). 
 Although the medical management of CHD has improved, patients still face many 
psychological and social issues.  Graham draws attention to the fact that frequent 
hospitalizations, absences from school, and the inability to keep up with peers in physical 
activity can lead CHD patients to feel isolated and different (2012).  The same review 
also indicates an increased risk for anxiety, depression, aggression, and hyperactivity 
amongst CHD patients when compared to healthy peers (2012).  Most importantly, better 
medical management of CHD has not necessarily led to more favorable psychological 
and social outcomes (Graham, 2012).  With an increased population of CHD patients 
entering adolescence and adulthood, this transition should be managed on more than a 
strictly medical level. 
 Although the American Heart Association recommends the use of formal 
transition programs for CHD patients, outcome data on successful transition programs is 
lacking.  Many studies have used transfer rates to adult care providers as a metric to 
determine success of transition, but this metric limits the ongoing process of transition to 
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the particular moment of transfer.  Furthermore, transfer rates to adult care specialists is 
very low among CHD patients, which is disconcerting given the complexity of some 
defects (Bono and Freeman, 2005; Bono, 2005; Mackie et al., 2009; Reid et al., 2004; 
Yeung, 2008; Wacker et al., 2005).  Certain agreed upon ideals of transition, such as 
increasing self-efficacy in the patient, are beginning to lead to better QoL outcomes.  
However, the CHD population is still in need of formal transition programs to aid the 
patient as they enter adulthood. 
 Approximately 40,000 CHD patients are born yearly, and 1 in 4 of these patients 
will need surgery in the first year of life (“Data & Statistics”, 2015).  While surgical and 
medical management of CHD has starkly improved, QoL and psychosocial issues still 
remain a burden as patients enter adolescence and adulthood.  Formal transition programs 
may play a role in limiting these issues, but outcome data on successful programs is 
lacking. 
 
Normal Blood Flow 
	
In a healthy person, blood flows in a constant pattern: body-heart-lungs-heart-body.  
Figure 1 demonstrates this pattern, while also displaying how the heart maintains separate 
but equal blood flow in the pulmonary and systemic circulations.   
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Figure 1: Blood Flow in a Normal Heart.  Cross-sectional view of blood flow through 
the heart.  Blue arrows represent deoxygenated blood, while red arrows represent 
oxygenated blood.  Figure taken from “Structure and Function: The Heart Before and 
After Birth”, 2017. 
 
 
The blue arrows in Figure 1 represent the deoxygenated systemic venous return, which 
passes from the vena cava to the right atrium and right ventricle during diastole.  
Simultaneously, the oxygenated pulmonary venous return (represented by the red arrows 
in Figure 1) collects in the left atrium and left ventricle.  During systole, deoxygenated 
blood is ejected from the right ventricle through the pulmonary arteries to the lungs, 
while oxygenated blood is pumped from the left ventricle through the aorta to the rest of 
the body.  By maintaining separate but equal blood flow in the pulmonary and systemic 
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circulations, the heart ensures that all the deoxygenated blood returning from the body 
becomes oxygenated, and that all the oxygenated blood returning from the lungs is sent 
throughout the body.  As long as this process is not compromised, the cardiovascular 
system performs many vital functions: it supplies oxygen and nutrients to cells 
throughout the body, removes carbon dioxide and waste, transports immune cells and 
hormones, and regulates body temperature. 
 
Blood Flow in Septal and Valve Defects. 
 
 CHDs may disrupt the natural blood flow in the heart, often allowing 
deoxygenated and oxygenated blood to mix.  This can cause lower flow of oxygen and 
nutrient rich blood to vital organs.  Figure 2 demonstrates how a small hole in the septum 
between the two atria, called an Atrial Septal Defect, enables oxygen rich blood from the 
left atrium to mix with deoxygenated blood in the right atrium.  Similar to ASDs, 
Ventricular Septal Defects are lesions in the septum that separates the two ventricles.  
VSDs also present an alternate pathway for blood to flow, as blood may flow from the 
left ventricle directly to the right ventricle.  For septal defects, the size of the lesion 
affects the severity of symptoms, which may include tachycardia, difficulty breathing, 
difficulty feeding, pulmonary hypertension, pulmonary blood vessel damage, and 
congestive heart failure (“Atrial Septal Defect (ASD)”, 2015; “Ventricular Septal Defect 
(VSD)”, 2015).  According to the AHA, cardiac catheterization or open heart surgery 
may be necessary for larger septal defects (2015). 
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Figure 2: Atrial Septal Defect.   Cross-sectional view of a heart with an Atrial Septal 
Defect.  The higher resistance in the systemic circulation causes oxygenated blood to pass 
from the left atrium to the right atrium, rather than returning to the body.  Figure taken 
from “Atrial Septal Defect (ASD)”, 2015. 
 
 
 Valve defects range in severity from less critical cases of Pulmonary and Aortic 
Valve Stenosis to life-threatening defects such as Ebstein’s Anomaly.  Pulmonary Valve 
Stenosis and Aortic Valve Stenosis involve thickened or fused valve tissue which 
prevents the pulmonary or aortic valve from opening properly.  Symptoms include heart 
murmurs, ventricle hypertrophy, fatigue, difficulty breathing, difficulty feeding, 
lightheadedness, syncope, angina and cyanosis (“Aortic Valve Stenosis (AVS)”, 2015; 
“Pulmonary Valve Stenosis”, 2015).  In severe cases, cardiac catheterization by balloon 
valvuloplasty or open heart surgery is necessary to fix either Pulmonary Valve Stenosis 
or Aortic Valve Stenosis (“Aortic Valve Stenosis (AVS)”, 2015; “Pulmonary Valve 
Stenosis”, 2015). 
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For patients with Ebstein’s Anomaly, the tricuspid valve cannot close properly, 
and blood flows from the RV back into the RA.  According to the Mayo Clinic, 
symptoms may include supraventricular tachycardia, palpitations, chest discomfort, 
dizziness, lightheadedness, syncope, cyanosis and congestive heart failure (2016).  Open 
heart surgery may be necessary to repair or replace the tricuspid valve (“Ebstein’s 
Anomaly”, 2016). 
 Combination of less severe CHDs can cause a serious threat to life for the 
newborn.  Complete Atrioventricular Canal defect, as shown in Figure 3, is a large hole 
in the septum of the heart where the atria and ventricles meet.   
 
Figure 3: Complete Atrioventricular Canal Defect.  Cross-sectional view of a heart 
with CACV.  A large hole is present in the septum, combining the four chambers of the 
heart and allowing oxygenated and deoxygenated blood to mix.  The tricuspid and mitral 
valves combine to form one large valve in the center of the heart.  Figure taken from 
“Complete Atrioventricular Canal defect (CAVC)”, 2015. 
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This hole joins all four chambers of the heart, allowing oxygenated and deoxygenated 
blood to mix.  The tricuspid and mitral valves also fail to form properly, and a single 
valve between the two atria and the two ventricles takes their place.  According to the 
AHA, a large left-to-right shunt occurs, leading to symptoms such as a tachycardia, 
difficulty breathing, difficulty feeding, pulmonary hypertension, pulmonary blood vessel 
damage, and congestive heart failure (2015).  Banding of the pulmonary artery may 
reduce blood flow to the lungs short-term, but CAVC usually requires open heart surgery 
to repair the lesion during infancy (“Complete Atrioventricular Canal defect (CAVC)”, 
2015). 
 
Blood Flow in Other Congenital Heart Defects. 
  
Patent Ductus Arteriosus: In the fetal circulation, the ductus arteriosus allows blood to 
flow directly from the pulmonary artery to the aorta, bypassing the nonfunctioning lungs.  
If the lumen of the ductus does not close during the first 72 hours of life, a PDA remains 
which directly connects the pulmonary and systemic circulations (“Patent Ductus 
Arteriosus (PDA)”, 2015).  Larger resistance in the systemic circulation results in left-to-
right shunting though the PDA during diastole, and symptoms include murmurs, 
difficulty breathing, difficulty feeding, pulmonary hypertension and pulmonary blood 
vessel damage (“Patent Ductus Arteriosus (PDA)”, 2015).  If the PDA is large enough, 
medications may be administered to close the PDA during early infancy, or 
catheterization may be performed (“Patent Ductus Arteriosus (PDA)”, 2015). 
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Coarctation of the Aorta: Coarctation of the Aorta is a narrowing of the aorta, placing an 
increased demand on the LV.  According to the AHA, symptoms include LV 
hypertrophy, hypertension, and congestive heart failure (2015).  In severe cases, cardiac 
catheterization or open heart surgery may be necessary (“Coarctation of the Aorta 
(CoA)”, 2015). 
 
d-Transposition of the Major Arteries: d-transposition occurs when the aorta is connected 
to the RV and the pulmonary artery is connected to the LV.  Deoxygenated blood never 
reaches the lungs, while oxygenated blood never circulates throughout the body.  Surgical 
intervention is necessary for survival of the newborn, and patients undergo either an atrial 
switch or arterial switch (“d-Transposition of the great arteries”, 2015).  Patients who 
undergo an atrial switch experience a decline in heart function overtime, as the RV is 
responsible for pumping to the entire systemic circulation, while arrhythmias are also 
common (“d-Transposition of the great arteries”, 2015). 
 
 
l-Transposition of the Major Arteries: l-transposition occurs when both the ventricles and 
the major arteries are reversed.  The RA is connected to the LV, and the LA is connected 
to the RV.  The pulmonary artery is connected to the LV, and the aorta is connected to 
the RV, so blood flows normally.  Symptoms include decline in heart function, 
arrhythmias, heart murmurs, cyanosis and congestive heart failure (“l-Transposition of 
the great arteries”, 2015).  Most patients will only require medicine to help the heart beat 
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faster, although those with complex cases or additional CHDs may need surgery (“l-
Transposition of the great arteries”, 2015). 
 
Hypoplastic Left Heart Syndrome: Patients with HLHS have an underdeveloped LV, 
mitral valve, aortic valve, and aorta.  The LV and aorta are too small for adequate blood 
flow, while the mitral and aortic valves fail to open properly.  In order for oxygenated 
blood to reach the body, blood must flow from the LA to the RA through an ASD and 
then to the aorta through a PDA.  According to the AHA, symptoms include heart 
murmurs, rapid heartbeat, difficulty breathing, and cyanosis (2015).  Prostaglandins may 
be administered to maintain the PDA until surgery can take place (“Single Ventricle 
Defects”, 2015).  Surgery is necessary and occurs in three parts: Norwood procedure (a 
new aorta is connected to the RV), Bi-directional Glenn Shunt (superior vena cava is 
connected directly to the pulmonary artery), and the Fontan Procedure (inferior vena cave 
is connected directly to the pulmonary artery) (“Single Ventricle Defects”, 2015). 
 
Pulmonary Atresia: Pulmonary Atresia occurs when the pulmonary valve does not form 
properly, and blood cannot reach the lungs though the RV.  Deoxygenated blood flows 
from the RA to the LA through an ASD, and eventually reaches the lungs through a PDA. 
Newborns will present as cyanotic, and drugs must be administered to maintain a PDA 
until surgeons can create a shunt between the pulmonary artery and aorta (“Single 
Ventricle Defects”, 2015). 
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Tricuspid Atresia: Patients with Tricuspid Atresia have no tricuspid valve, and blood 
cannot flow from the RA to the RV.  Blood must flow from the RA to the LA through an 
ASD, and then pass from the LV to the RV through a VSD.  Patients present as cyanotic, 
and surgery is necessary (“Single Ventricle Defects”, 2015).  Patients with Tricuspid 
Atresia can undergo the Bi-directional Glenn Shunt and Fontan procedures to increase 
heart function (“Single Ventricle Defects”, 2015). 
 
Tetralogy of Fallot: TOF is a combination of four major heart defects: VSD, Pulmonary 
Valve Stenosis, aorta transposition, and hypertrophy of the RA.  Patients present as 
cyanotic and surgical intervention is necessary (“Tetralogy of Fallot”, 2015).  A 
temporary shunt may be placed between the aorta and pulmonary artery to allow 
increased blood flow to the lungs, while complete repairs may be done by closing the 
VSD and repairing the pulmonary valve (“Tetralogy of Fallot”, 2015). 
 
Total Anomalous Pulmonary Venous Connection: TAPVC is a defect in which 
pulmonary veins connect to the heart in abnormal positions, leading to fluid buildup and 
congestion in the lungs.  ASD accompanies TAPVC, allowing blood to flow from the RA 
to the LA and LV.  Symptoms include difficulty breathing and cyanosis, and surgery 
must be performed to reconnect the pulmonary veins to the LA and close the ASD 
(“Total Anamolous Pulmonary Venous Connection (TAPVC)”, 2015). 
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Truncus Arteriosus: Truncus Arteriosus is a defect that involves the major arteries of the 
heart.  Rather than having two separate arteries connected to the RV and LV, one major 
artery connects to one large ventricle created by a VSD.  The truncus eventually branches 
to both the lungs and the body.  Symptoms include pulmonary hypertension, difficulty 
breathing and cyanosis (“Truncus Arteriosus”, 2015).  Surgery is performed to close the 
VSD, while the pulmonary arteries are removed from the truncus and reconnected to a 
tube that is placed in the RV (Rastelli repair) (“Truncus Arteriosus”, 2015).
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METHODS 
 
 Many sources including scientific statements, systematic reviews, medical journal 
articles, textbooks, and medical information web sources were studied to gain 
information on the changing state of patients with CHD.  Websites for the National Heart, 
Lung, and Blood Institute, the American Heart Association and the Centers for Disease 
Control provided data on the current status of CHD in the United States, pathophysiology 
for the different types of CHD, and recommendations of journal articles to gain more 
information.  The data contained in these websites had been updated in 2011 (NHBLI) 
and 2015 (AHA and CDC).  Medical journal articles, especially those found in 
Pediatrics, The Journal of Pediatrics, and Circulation, provided most of the data found in 
the results.  Many articles that discussed the changing prevalence and survival rates for 
CHD were published in the early 2000s, while articles that discussed the psychosocial 
issues CHD patients face were published more recently.  Overall, the journals used in this 
paper were published from 2000 to 2016.  While most data regarding the prevalence and 
survival rates of CHD came from the United States and more specifically the MACDP, 
sources for information on psychosocial issues, transition, and transfer of care came from 
a range of countries.  Articles from Iran, Portugal, UK, Canada, Belgium, Taiwan, 
Germany and Norway all contributed information that was used in this paper. 
 PubMed was the main engine used to search for articles regarding the status of 
CHD patients.  Beginning with a search for transition of CHD patients, a scientific 
statement on the transition management of CHD patients published in Circulation by the 
AHA served as a template for the current state of CHD in the United States and what 
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needed to be further researched.  Searches for prevalence, survival rates, psychosocial 
issues, transition, and transfer of care provided many results, while the similar articles tab 
was also used to find important related articles.  Bibliographies from useful papers were 
also used to find related articles and further information on CHD that was not 
immediately discovered on PubMed. 
 When searching for journal articles, it became very apparent that the amount of 
objective information far outweighed the amount of subjective information.  While 
articles on prevalence, survival, and efficacy of diagnostic and surgical techniques were 
readily available, articles on QoL and successful transition programs were difficult to 
find.  Furthermore, much of the research that used subjective measures for QoL and 
psychosocial issues was conflicting. 
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RESULTS 
	
 Over the past few decades, CHD prevalence increased in the United States.  Table 
1 demonstrates a specific example, as the detection of all CHD cases increased in the 
Metropolitan Atlanta Congenital Defects Program (MACDP) from 1979-2005. 
Table 1.  MACDP CHD Prevalence.   
Period Births Cases per 10,000 Live Births (95% CI) 
  All CHDs All CCHDs CCHD 
Primary 
Targets 
1979-1986 228 566 50.1 (47.3-
53.1) 
17.1 (15.5-
18.9) 
11.9 (10.5-
13.4) 
1987-1993 264 060 55.0 (52.3-
57.9) 
16.4 (14.9-
18.0) 
11.3 (10.1-
12.6) 
1994-1999 255 847 68.9 (65.8-
72.2) 
17.9 (16.4-
19.7) 
11.3 (10.1-
12.7) 
2000-2005 308 068 84.5 (81.3-
87.8) 
17.8 (16.4-
19.3) 
11.2 (10.1-
12.5) 
Total 1 056 541 65.9 (64.4-
67.5) 
17.3 (16.5-
18.1) 
11.4 (10.8-
12.1) 
MACDP CHD prevalence per 10,000 live births by time period and CHD severity, 1979-
2005.  Displayed with 95% Confidence Interval.  Table recreated from Oster et al., 2013. 
 
 
The prevalence increased from 50.1 CHD cases per 10,000 live births in 1979-1986 to 
84.5 CHD cases per 10,000 live births in 2000-2005 (Oster et al., 2013).  The detection of 
all CCHDs remained constant at approximately 17 cases per 10,000 live births (Oster et 
al., 2013).  This data reflected previous research conducted in the same region, as the 
prevalence of all CHDs increased from 62.0 per 10,000 live births in 1968-1997 to 90.2 
per 10,000 live births in 1995-1997 (Botto et al. 2001).  Higher detection of less severe 
defects accounted for a large proportion of the increase, as Atrial Septal Defects, 
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Ventricular Septal Defects, and peripheral pulmonic stenosis were responsible for 55.9% 
of the increase in prevalence (Botto et al., 2001).  Figure 4 supports this trend, as septal 
defects (B) and less severe valve defects (E) mirror the surge in prevalence experienced 
by all heart defects (A).    
   
Figure 4: CHD Prevalence by Type.  MACDP CHD prevalence by year and by type of 
defect, 1968-1997.  A: all heart defects; B: septal defects; C: TOF and Transposition of 
the Great Arteries; D: HLHS and Coarctation of the Aorta; E: valve defects and 
peripheral stenosis; F: septal defects with and without Down Syndrome.  Figure taken 
from Botto et al., 2001. 
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As shown in Figure 4, the detection of Ventricular Septal Defects increased from 
approximately 10 cases per 10,000 live births to 25 cases per 10,000 live births from 
1968-1997.  During the same time period, the prevalence of Atrial Septal Defects 
increased from approximately 0 cases per 10,000 live births to 10 cases per 10,000 live 
births.  Peripheral pulmonary stenosis also increased in frequency, as detection increased 
from approximately 0 cases per 10,000 live births to 7 cases per 10,000 live births.  The 
prevalence curves for these three defects closely mirrored the prevalence curve for all 
CHDs, as they accounted for a majority of the increase in CHD detection.  Although 
some CCHDs, such as transposition of the great arteries, experienced significant 
increases in prevalence, many CCHDs experienced only slight increases in frequency or 
remained the same (Botto et al., 2001). 
 While CHD prevalence increased during this time period, the number of missed 
CHD diagnoses decreased.   
 
Figure 5:  Missed CCHD Diagnoses by Year.  The number of deaths due to CCHD by 
year, 1989-2004.  Black dot: study cohort (CHD diagnosis); black square: unknown 
diagnosis; white dot: missed CCHD diagnosis.  Figure taken from Chang et al., 2008. 
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Figure 5 shows a decrease in both the deaths due to CCHD, and a decrease in the deaths 
due to missed diagnosis of CCHD in California.  Specifically, the number of deaths 
caused by missed CCHD diagnoses in California decreased from approximately 20 in 
1989 to fewer than 10 in the early 2000s (Chang et al., 2008). 
 Figure 6 reveals that timely diagnosis of CCHD is of utmost importance to the 
newborn.  
	
 
 
Figure 6: CHD Survival Probability by Age.  Survival probability versus age of the 
patient.  Blue: noncritical CHDs; yellow: CCHDs.  Figure taken from Oster et al., 2013. 
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As shown in Figure 6, CCHD patients faced a significantly higher threat of death during 
infancy than noncritical CHD patients.  Threat of mortality was also the highest during 
the first year of life, shown by the steep slope for CCHD patients during infancy.  Only 
75.2% of CCHD patients survived to 1 year of age according to MACDP data. 
 While CHD prevalence increased from 1979-2005, CHD mortality rates 
decreased during a similar time period.  Table 2 shows the decrease in both age at death 
and total numbers of deaths for CHD patients. 
Table 2.  CHD Mortality Temporal Trends.   
 
1979-1983 1984-1988 1989-1993 1994-1997 
Age at 
Death 
No. of 
Death
s 
Age at 
Death 
No. of 
Death
s 
Age at 
Death 
No. of 
Death
s 
Age at 
Death 
No. of 
Death
s 75
% 
50
% 
75
% 
50
% 
75
% 
50
% 
75
% 
50
% 
252 6 35 357 300 6 32 870 372 7 32 941 492 12 23 653 
Age at death (months) for CHD patients in the 50th and 75th percentile by time period, 
1979-1997.  Total number of CHD related deaths by time period also shown.  Table 
recreated from Boneva et al., 2001. 
 
 
As shown in Table 2, the median age at death for CHD patients in the United States 
increased from 1979 to 1997.  The age at death for the 50th percentile improved from 6 
months in 1979-1983 to 12 months in 1994-1997, while the age at death for the 75th 
percentile increased from 252 months in 1979-1983 to 492 months in 1994-1997 (Boneva 
et al., 2001).  The same study also showed the total number of CHD related deaths 
decreasing from 1979-1997.  As shown in Figure 7, the CHD mortality rate decreased by 
nearly 39% in the United States between 1979 and 1997 (Boneva et al., 2001).  
	20 
Furthermore, the same study revealed that CHD mortality dropped steadily at 
approximately 1.9% per year over the same time period (2001).  For patients <4 years of 
age, mortality decreased at approximately 2.7% per year, and total mortality decreased by 
nearly half (Boneva et al., 2001).  The total number of CHD deaths has decreased as well, 
as there were 7,169 deaths due to CHD in 1979-1981 and 5,822 deaths due to CHD in 
1995-1997 (Boneva et al., 2001). 
 
Figure 7: CHD Mortality by Year.  CHD related deaths per 100,000 by year, 1979-
1997.  Figure taken from Boneva et al., 2001. 
 
 
Additionally, 1-year survival rates for patients with CHD increased significantly 
over a similar time period.  According to MACDP data, 1-year survival for patients with 
CCHD improved from 67.4% in 1979-1993 to 82.5% in 1994-2005 (Oster et al., 2013).  
A recent study from Europe revealed that the 1-year survival rate for CHD increased 
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from 90.7% in 2000-2004 to 96.5% in 2005-2011 (Erikssen et al., 2014).  The 18-year 
survival rate for CHD patients also improved over the past few decades.  Approximately 
95% of patients with a non-critical defect and 69% of patients with a critical defect were 
estimated to survive to age 18 (Oster et al., 2013).  Erikssen et al. revealed a similar 
trend, as the 16-year CHD survival rate increased from 62.4% in 1971-1989 to 86.9% in 
1990-2011 (2014).  With the increased survival rate, a larger proportion of CHD patients 
entered adolescence and adulthood.  Approximately 1 million adults were estimated to 
live with CHD, slightly more than the childhood population (Mirelli et al., 2012).  
 Limperopoulous et al. observed that >50% of newborns who underwent open 
heart surgery to fix cyanotic lesions had neurodevelopmental disabilities pre-surgery, and 
that their status was unchanged post-surgery (2000).  For infants undergoing open heart 
surgery, neurodevelopmental disabilities were reported in 38% before surgical 
intervention (Limperopoulous et al., 2000).  There was also a significant association 
between oxygen saturations <85% and a developmental disability (Limperopoulos, 
2000).  Patients with acyanotic defects were also more likely than the general population 
to have subnormal mental level (10%; N=132) and at least one specific developmental 
disorder (25%; N=132) (Ozmen et al., 2016).  Jerrell et al. reported that those who 
required cardiac or non cardiac surgery were at a significantly higher “risk of developing 
neurologic disorders, mental retardation, developmental delay, or hyperactivity” (2015).  
Similar results were found for those who experienced low oxygen saturation (Jerrell et 
al., 2015).  
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 Shillingford et al. discovered that CCHD patients scored 3 to 4 times higher than 
healthy controls for inattention and hyperactivity on the Behavior Assessment System for 
Children (2008).  Parents of CCHD patients also reported high-risk scores for inattention 
(30%) and hyperactivity (29%) on the Attention-Defecit/Hyperactivity Disorder Rating 
Scale-IV (Shillingford et al., 2008).  As many as 49% (N=109) of these patients were 
receiving special education services (Shillingford et al., 2008). 		MACDP data revealed 
that children with any type of CHD, not only those requiring surgery, were 50% more 
likely to require special education services than healthy controls (Riehle-Colarusso et al., 
2015).  CHD patients were also more likely to have intellectual disability, sensory 
impairment, significant developmental delay, or specific learning disability (Riehle-
Colarusso et al., 2015).  
 
Figure 8: Adverse Outcomes for CHD Patients Versus Healthy Controls.  Percentage 
of children experiencing adverse psychosocial outcomes, by age and presence of CHD.  
Figure taken from Razzaghi et al., 2015. 
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Figure 8 displays that CHD patients age 0-17 years (N=420) were more likely to have 
autism, ADHD/ADD, and intellectual disability than their healthy peers according to the 
National Health Interview Survey.  They were also more likely to have seen mental 
health professionals, and were at a greater risk to miss 10+ days of school than the 
general population (Razzaghi et al., 2015). 
 
Figure 9: PedsQL Scores for CHD Patients and Healthy Classmates.  Frequency of 
PedsQL scores for CHD patients versus healthy classmates.  Overall scores, physical 
functioning scores and psychosocial functioning scores presented.  Higher PedsQL score 
correlates with higher QoL.  Figure taken from Knowles et al., 2014. 
 
 
Figure 9 shows that patients with CHD scored lower PedsQL scores relating to both 
physical and psychosocial functioning when compared with healthy classmates.  Knowles 
et al. also found specific correlations between cardiac interventions, school absences, the 
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need to take regular medications, non-cardiac comorbidities and a lower QoL (2014). 
While this data reflected lower quality of life scores on the PedsQL scale, many studies 
presented conflicting data on QoL scores for CHD patients. 
 
Table 3.  IQLC Self-Assessment Scores for CHD Patients.  
 
IQLC self 
assessment 
Mean score 
(SD) in 
normal 
children 
Mean score 
(SD) in 
group A 
p value Mean score 
(SD) in 
group B 
p value 
School 2.02 (0.77) 2.08 (0.79) >0.2 2.11 (0.78) >0.2 
Family 1.40 (0.57) 1.59 (0.75) 0.06 1.62 (0.77) 0.05 
Other 
children 
1.59 (0.80) 1.65 (0.68) >0.2 1.59 (0.66) >0.2 
Loneliness 1.87 (0.92) 1.92 (0.86) >0.2 1.94 (0.84) >0.2 
Health 1.93 (0.87) 1.47 (0.72) 0.002 1.41 (0.67) 0.0005 
Humor/nerves 2.00 (0.71) 2.04 (0.72) >0.2 2.06 (0.72) >0.2 
Total quality 
of life 
1.62 (0.66) 1.64 (0.59) >0.2 1.63 (0.57) >0.2 
IQLC scores for normal children (n=53), all CHD patients (Group A; n=60), and CHD 
patients with severe neurological damage (Group B; n=54).  Scores range from very good 
(1) to very bad (5).  Table recreated from Hovels-Gurich, 2002. 
 
 
Table 3 reveals that self reported quality of life scores on the IQLC self assessment for 
patients that have undergone arterial switch for TGA did not differ significantly from 
healthy controls.  While the median score reflected slightly lower quality of life in 
categories of school, family, other children, loneliness, humor/nerves and total quality of 
life, there were no statistically significant differences between CCHD patients having 
undergone atrial switch and their healthy peers.  On the Achenbach Child Behavioral 
Checklist (CBCL), teachers reported no statistically significant difference between CHD 
patients who had undergone cardiac surgery 4-8 years previous (n=168) and healthy 
	25 
controls (n=51) on both the behavioral and social scales (Hovels-Gurich, 2002).  
However, parents have reported adverse scores for their children with CHD on the 
CBCL.  Table 4 reveals that for children who underwent arterial switch for TGA, parents 
reported significantly higher risks for internalizing problems, externalizing problems, and 
social problems on the behavioral scale.  On the social scale, CHD patients also scored 
significantly worse on matters of social involvement, social performance, and total 
competence than healthy peers (Hovels-Gurich, 2002). 
Table 4.  Parent Reported CBCL Scores for CHD Patients.   
 
CBCL 
assessed by 
parents 
Score Frequency 
in normal 
children 
(%) 
Frequency 
in group 
A (%) 
p value Frequency 
in group B 
(%) 
p value 
Internalizing 
problems 
<60 84 65 0.0005 63 0.0003 
 60-63 6 7  8  
 >63 10 28  29  
Externalizing 
problems 
<60 84 72 0.006 72 0.001 
 60-63 6 17  16  
 >63 10 11  12  
Social 
problems 
<67 95 89 0.0001 90 0.0001 
 67-70 3 0  0  
 >70 2 11  10  
Attention 
problems 
<67 95 87 0.05 86 0.03 
 67-70 3 7  8  
 >70 2 6  6  
Total 
behavioural 
problems 
<60 84 63 0.0001 61 0.0001 
 60-63 6 7  6  
 >63 10 30  33  
Social 
involvement 
<30 2 15 <0.0001 4 >0.2 
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CBCL 
assessed by 
parents 
Score Frequency 
in normal 
children 
(%) 
Frequency 
in group 
A (%) 
p value Frequency 
in group B 
(%) 
p value 
Social 
involvement 
30-33 3 3  4  
 >33 95 82  92  
Social 
performance 
<30 2 8 0.0005 0 0.001 
 30-33 3 10  14  
 >33 95 82  86  
Total 
competence 
<30 2 15 <0.0001 4 >0.2 
       
 30-33 3 2  0  
 >33 95 83  96  
Parent reported CBCL scores for normal children (n=2856), all CHD patients (Group A; 
n=60), and CHD patients with severe neurological damage (Group B; n=54).  Scores <60, 
<67, and >33: no problems; scores 60-63, 67-70, and 30-33: borderline problems; scores 
>63, >67, and <30: striking problems.  Table recreated from Hovels-Gurich, 2002. 
 
 
 A systematic review was conducted on the psychological adjustment and quality 
of life for adolescents following open-heart surgery, and Latal et al. observed an 
increased risk for psychological maladjustment among CHD patients when compared to 
healthy controls (2009).  This was especially true when reported by parents on the CBCL.  
When it came to self-reporting, the data on psychological functioning was conflicting; 
many studies found no differences from healthy controls, whereas one reported increased 
depression among school-aged children and another observed self-reported behavioral 
problems in adolescents (Latal et al., 2009).  QoL data was highly conflicting, although 
some studies reported lower QoL for children having undergone cardiac surgery for 
complex congenital heart defects (Latal et al., 2009).  Overall, the review concluded a 
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higher risk for psychological maladjustment among post-operative CCHD patients, while 
there was also potential for lower QoL (Latal et al., 2009). 
 While this systematic review dealt with CCHD patients who had undergone 
surgery, other studies were conducted on CHD patients in general.  Karsdorp et al. 
discovered that older CHD patients were at higher risk for internalizing and externalizing 
problems, while CHD patients across all age groups demonstrated lower cognitive 
functioning (2006).  Additionally, Karsdorp et al. discovered that those with more critical 
types of CHDs displayed poorer cognitive functioning than those with less critical types 
(2006).  Uzark et al. observed that as many as 21% of children <8 with any type of CHD 
self-reported significantly lower PedsQL scores (2008).  19.2% of those with less severe 
types of CHD also reported lower PedsQL scores (Uzark et al., 2008).  
 In Portugal, Areias et al. discovered that CHD patients who had undergone 
surgery scored significantly lower QoL scores than both CHD patients without surgery 
and the general population in the physical, psychological, relationship, environmental and 
general categories.  This data is presented in Table 5, which shows higher mean QoL 
scores for patients not having undergone surgery.  Areias et al. also found a correlation 
between good social support and higher QoL scores, as shown in Table 6.  Qualitatively, 
CHD patients have reported “feeling ‘different’ and set apart from their peers” (Graham, 
2012).  Low perceptions of self-efficacy, feeling uncertain about their future, and being 
unaware of their life expectancy were also common themes among CHD patients in 
Graham’s study (2012).   
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Table 5: QoL Scores for CHD Patients with Surgery Versus without Surgery.   
 
Dimensions With surgery 
(N=114) 
Without surgery 
(N=36) 
T P 
M SD M SD 
Physical 25.44 3.875 27.81 3.658 -3.270 0.001 
Psychological 22.65 2.934 24.27 2.305 -3.069 0.003 
Social 
Relationships 
11.79 1.830 12.51 1.710 -2.128 0.035 
Environmental 31.05 4.381 32.62 3.094 -2.396 0.019 
General QOL M   M  U P 
7.80  8.32  1,505.00 0.006 
Mean QoL scores and Standard Deviations for CHD patients having undergone surgery 
and without surgery.  Higher score correlates with higher QoL.  Table recreated from 
Areias et al., 2013. 
 
 
Table 6: QoL Scores for CHD Patients with Good Social Support Versus Poor 
Social Support.   
 
Dimensions Good SS (N=117) Poor SS (N=33) T P 
M SD M SD 
Physical 26.39 3.893 24.73 3.915 2.168 0.032 
Psychological 23.37 2.797 21.91 2.887 2.627 0.010 
Social 
relationships 
12.26 1.647 10.91 2.037 3.956 0.000 
Environmental 32.00 3.991 29.45 4.139 3.210 0.002 
General QOL M  M  U P 
8.09  7.33  1,233.000 0.001 
Mean QoL scores and Standard Deviations for CHD patients with good social support 
and with poor social support.  Higher score correlates with higher QoL.  Table recreated 
from Areias et al., 2013. 
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While it was proven that many CHD patients still engage in risky behavior (sexual 
activity, smoking cigarettes, using illicit drugs, and binge drinking), their participation 
was comparable or lower to healthy peers of the same age (Graham, 2012).  Furthermore, 
CHD patients reported that a lower stamina while drinking alcohol led to feelings of 
isolation (Graham, 2012).  Additionally, the bullying and discrimination they faced from 
their peers when trying to socially integrate left them with feelings of anger and exclusion 
(Graham, 2012).  Spijkerboer et al. revealed that CHD patients and parents both reported 
similar prevalence of behavioral and emotional problems in 1990-1995 when compared 
to historical patients of the same age before 1980 (2008).  
Many countries around the world have reported less than optimal transfer rates 
from pediatric cardiologists to adult care cardiologists for patients with CHD.  In 
Toronto, Reid et al. discovered that less than half (47%) of children born with a CHD 
followed up at least once to an adult CHD center (ACHD) in the Canadian Adult 
Congenital Heart Network (CACH) (2004).  As many as 27% had no follow-up with any 
cardiologist after turning 18 years old (Reid et al., 2004).  There were statistically 
significant associations made between successful transfer and high numbers of surgeries, 
cardiologist visits close to turning 18, and documented recommendations for follow-up at 
an ACHD (Reid et al., 2004).  In Quebec, Mackie et al. revealed that 61% of 22 year olds 
with CHD failed to follow-up with any form of cardiac care after turning 18 years old 
(2009).  As many as 47% with moderate or complex CHD and 21% with complex CHD 
failed to follow-up as well (Mackie et al., 2009).   
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Figure 10 demonstrates a study population that experienced a steady decline in 
follow-up starting in childhood.  
 
Figure 10: CHD Patient Attrition by Age.  Number of cohort study patients lost to 
follow-up by age.  Figure taken from Mackie et al., 2009. 
 
 
177 patients failed to follow-up between ages 6 and 12, another 123 failed to see a 
cardiologist between ages 13 and 17, and 94 more patients were lost between ages 18 and 
22 (Mackie et al., 2009).  In total, 394 of 643 patients (61%) were lost to attrition from 
birth to age 22 (Mackie et al., 2009).   
Mackie et al. also discovered that patients with less severe defects were less likely 
to follow-up with cardiologists over time, as shown in Figure 11.  Those with simple 
defects experienced steady decline in follow-up over their lifetime, while those with 
univentricular hearts continued to see cardiologists at age 18.  Other severe and moderate 
defects experienced a decline in follow-up that occurred at older ages. 
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Figure 11: Patient Follow-up by Defect.  Percentage of CHD patients that follow-up 
with cardiologists by age and type of defect.  Black square: univentricular hearts; black 
dot: conotruncal anomalies; black triangle: endocardial cushion defects; white square: left 
outflow lesions; white diamond: simple shunts.  Figure taken from Mackie et al., 2009. 
 
 
In Germany, Wacker et al. reported that more than 76% (8,028 out of 10,500) of 
patients with CHD experienced a gap in follow-up for >5 years (2005).  Figure 12 shows 
that from the 8,028 patients who experienced this gap, only 1,941 replied to a 
questionnaire.  1,256 claimed to be asymptomatic at all levels of activity, 598 did not 
have symptoms that affected everyday activities, 54 had symptoms that affected most but 
not all everyday activities, and 20 were extremely limited in all activities.  In the UK, 
Bono revealed that as many as 39% (n=55) of patients with Coarctation of the Aorta 
failed to follow-up with at least some form of cardiac care for more than 2 years (Bono 
and Freeman, 2005; Bono, 2005).  Furthermore, of the 55 patients followed, 41% had 
hypertension (Bono and Freeman, 2005; Bono, 2005).  Similarly in Denver, Yeung 
discovered that 63% of patients with moderate or severe defects failed to follow-up at an 
ACHD clinic within two years of turning 18 (2008).  Of these patients, 32% were told 
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there was no need for follow-up, even though they were 3.1 times “more likely to require 
urgent cardiac intervention than healthy peers” (Yeung, 2008).  Furthermore, the median 
interval between turning 18 and follow-up at an ACHD center was 10 years (Yeung, 
2008). 
 
Figure 12: CHD Patients Lost to Follow-up by Limitation of Daily Activities.  
Number of patients lost to follow up according to limitation of daily activities.  FC1: 
asymptomatic; FCII: daily activities unaffected by symptoms; FCIII: symptoms limit 
most activities; FCIV: extremely limited in all activities.  Figure recreated from Wacker 
et al., 2005. 
 
 
In the United States, Goosens et al. reported that as few as 7.2% of 794 patients 
with CHD failed to follow up at a tertiary care center, while only 10.2% were receiving 
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less than the minimal level of cardiac care (2011).  Table 7 shows the level of care each 
CHD patient received in follow-up by defect.   
Table 7.  Number of CHD Patients Lost to Follow-up by Defect.   
 
Type of CHD Specialist 
Care 
Shared 
Care 
Nonspecialist 
Care 
No 
Follow-up 
Not 
Traceable 
Hypoplastic 
Left-heart 
Syndrome 
1     
Univentricular 
heart 
14     
Pulmonary 
Atresia 
without VSD 
2     
DORV 16  2   
DILV 1     
Truncus 
Arteriosus 
3     
TGA 28  2  1 
Congenitally 
corrected 
TGA 
3   1  
Coarctation of 
the Aorta 
80 5 2 3  
Aortic 
abnormality 
11 2  1  
Tetralogy of 
Fallot 
66 3 3   
Proportion of 
patients in 
each setting of 
follow-up 
90.0% 
(n=225) 
4.0% 
(n=10) 
3.6% (n=9) 2.0% (n=5) 0.4% (n=1) 
Number of patients following up at certain levels of care by defect.  N=250.  Table 
recreated from Goosens et al., 2011. 
 
 
For those requiring follow-up with specialists (n=250), a total of 5 patients did not 
follow-up with any care provider, while follow-up was not traceable for 1 patient.  Only 9 
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received less than the minimal level of cardiac care (nonspecialist).  Goosens et al. also 
discovered that those with complex defects (2.7% lost to follow-up) were less likely to be 
lost to follow-up than both those with moderate (6.9% lost to follow-up) and simple 
defects (9.2% lost to follow-up) (2011). 
 CHD patients also demonstrated a poor understanding of their defects and need 
for follow-up with an adult care specialist.  Table 8 shows documented patient answers to 
a series of questions involving the transition process.  Although many were able to 
answer questions about their condition correctly, only 36% fully understood the transfer 
process and only 30% understood how substance abuse could affect their condition.  As 
many as 31% of patients could not adequately describe their condition.  Clarizia et al. 
also found associations between patients knowing more about their condition and their 
ability to understand the transition process (100% versus 7%), while those who knew 
more about their condition were also likely to converse directly with their care providers 
(88% versus 33%) (2009).  Moons also reported patient answers to questions about their 
congenital heart defect, shown in Table 9.  As few as 48.4% of patients fully understood 
the reason for follow-up, while only 30.6% of patients could identify symptoms that 
would indicate a deterioration of their heart condition.  Furthermore, only 61.1% could 
accurately name their condition.  On questions about the anatomy of their defect and the 
appropriateness of different levels of physical activity, patients answered correctly 50-
80% of the time.  On questions about follow-up, genetic predisposition, deterioration of 
heart disease, and the effects of smoking and alcohol, they answered correctly less than 
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half the time.  Patients had a very poor understanding of endocarditis and their risks for 
acquiring the infection, as shown in Table 10. 
Table 8.  Patients’ Understanding of Their Defects.   
 
Patient interview (n=23) n (%) 
Do you know what the problem with your 
heart is? Yes 
17 (74) 
Describe the problem with your heart in 
your own words.  Accurate description 
16 (69) 
Do you take antibiotics when you go to the 
dentist? Yes 
17 (74) 
Explain why you need to take antibiotics 
when you go to the dentist.  Accurate 
explanation 
11 (48) 
What is the name of your doctor at 
SickKids?  Able to name 
18 (78) 
Tell me the name of your [heart] 
medication.  Able to name 
4/6 (67) 
Has a doctor or nurse discussed with you 
transition to an adult hospital?  Yes 
15/22 (68) 
Has a doctor or nurse talked to you about:  
Heart healthy eating choices.  Yes 10 (43) 
Physical activity in relation to your heart 
problem.  Yes 
17 (74) 
How taking drugs, alcohol or smoking 
could affect your heart problem.  Yes 
7 (30) 
Pregnancy in relation to your heart 
condition.  Yes 
5/8 (63) 
What is your understanding about who 
will look after your heart-related concerns 
after your 18th birthday?  Detailed and 
accurate answer 
8/22 (36) 
Number of CHD patients that correctly answer questions about their condition.  Table 
recreated from Clarizia et al., 2009. 
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Table 9.  Patients’ Understanding of Their Defects II.   
 
Question Correct 
(%) 
Incomplete 
(%) 
Does not 
know (%) 
Incorrect (%) 
What is the name of 
your heart defect? 
61.3 
(59.8 to 
62.8) 
4.8 (4.1 to 5.5) 14.5 (13.4 to 
15.6) 
19.4 (18.2 to 
20.7) 
Describe or indicate on 
the diagram where your 
heart defect is located 
50.0 
(48.4 to 
51.6) 
11.3 (10.3 to 
12.3) 
19.4 (18.2 to 
20.7) 
19.4 (18.2 to 
20.7) 
How often do you have 
to come to the clinic for 
follow up for your 
congenital heart 
disease? 
96.8 
(96.2 to 
97.4) 
- 0.0 (0.0-0.0) 3.2 (2.6 to 3.8) 
What is the main 
purpose of follow up? 
48.4 
(46.8 to 
50.0) 
48.4 (46.8 to 
50.0) 
0.0 (0.0-0.0) 3.2 (2.6 to 3.8) 
If the congenital 
cardiologist informs 
you that everything is 
alright, does that mean 
that you don’t need 
further follow up? 
98.4 
(98.0 to 
98.8) 
- 1.6 (1.2 to 
2.0) 
0.0 (0.0 to 0.0) 
How has your heart 
been treated to date? 
95.2 
(94.5 to 
95.9) 
1.6 (1.2 to 2.0) 1.6 (1.2 to 
2.0) 
1.6 (1.2 to 2.0) 
If you are on a drug 
treatment, give the 
name, dose, schedule, 
reason or function, 
most important side 
effects, and interactions 
with other drugs or 
foods (n=9) 
77.8 
(68.8 to 
86.9) 
11.1 (4.3 to 
17.9) 
0.0 (0.0 to 
0.0) 
11.1 (4.3 to 
17.9) 
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Question Correct 
(%) 
Incomplete 
(%) 
Does not 
know (%) 
Incorrect (%) 
If you experience side 
effects of your drugs, 
does this mean you 
should stop taking 
them? 
88.9 
(82.1 to 
95.7) 
- 11.1 (4.3 to 
17.9) 
0.0 (0.0 to 0.0) 
Do you have to follow 
a diet?  If you answer 
yes, please indicate the 
type of diet 
98.4 
(98.0 to 
98.8) 
0.0 (0.0 to 0.0) 0.0 (0.0 to 
0.0) 
1.6 (1.2 to 2.0) 
Mark all symptoms 
which may occur if 
your heart condition 
deteriorates and for 
which you have to 
contact your 
cardiologist 
30.6 
(29.1 to 
32.1) 
58.1 (56.5 to 
59.7) 
11.3 (10.3 to 
12.3) 
0.0 (0.0 to 0.0) 
 
Percentage of CHD patients that give either correct, incomplete, does not know, or 
incorrect answers to questions about their condition.  Table recreated from Moons, 2001. 
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Table 10.  Patients’ Understanding of Their Defects III.   
 
Question Correct (%) Does not 
know (%) 
Incorrect (%) 
What is endocarditis? 16.1 (14.9 to 17.3) 72.6 (71.2 to 
74.0) 
11.3 (10.3 to 
12.3) 
Indicate the most 
typical sign or 
sympom of 
endocarditis 
8.1 (7.2 to 9.0) 69.4 (67.9 to 
70.9) 
22.6 (21.3 to 
23.9) 
Can you only get 
endocarditis once in 
your lifetime? 
51.6 (50.0 to 53.2) 43.5 (41.9 to 
45.1) 
4.8 (4.1 to 5.5) 
As you have a 
congenital heart 
disease, should you 
take antibiotics 
immediately if you 
have a temperature 
(without consulting a 
physician)? 
83.9 (82.7 to 85.1) 3.2 (2.6 to 3.8) 12.9 (11.8 to 
14.0) 
Do the following 
factors contribute to 
the onset of 
endocarditis? 
   
Needle contamination 
(drug addicts) 
51.6 (50.0 to 53.2) 43.5 (41.9 to 
45.1) 
4.8 (4.1 to 5.5) 
Smoking 32.3 (30.8 to 33.8) 29.0 (27.6 to 
30.4) 
38.7 (37.2 to 
40.2) 
Bacteria from skin 
infections 
35.5 (34.0 to 37.0) 45.2 (43.6 to 
46.8) 
19.4 (18.2 to 
20.7) 
Dental abscesses 71.0 (69.6 to 72.4) 25.8 (24.4 to 
27.2) 
3.2 (2.6 to 3.8) 
Sexual activity 50.0 (48.4 to 51.6) 46.8 (45.2 to 
48.4) 
3.2 (2.6 to 3.8) 
Poor nail and skin care 9.7 (8.8 to 10.6) 53.2 (51.6 to 
54.8) 
37.1 (35.6 to 
38.6) 
Body piercing and 
tattooing 
29.0 (27.6 to 30.4) 46.8 (45.2 to 
48.4) 
24.2 (22.9 to 
25.6) 
Should you have a 
dental check up at 
least once a year? 
98.4 (98.0 to 98.8) 1.6 (1.2 to 2.0) 0.0 (0.0 to 0.0) 
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Question Correct (%) Does not 
know (%) 
Incorrect (%) 
Should you take 
antibiotics before 
every visit to the 
dentist? 
83.9 (82.7 to 85.1) 0.0 (0.0 to 0.0) 16.1 (14.9 to 
17.3) 
Do bleeding gums 
need extra attention? 
88.7 (87.7 to 89.7) 8.1 (7.2 to 9.0) 3.2 (2.6 to 3.8) 
Should you clean your 
teeth at least once a 
day? 
96.8 (96.2 to 97.4) 1.6 (1.2 to 2.0) 1.6 (1.2 to 2.0) 
Are smoking and 
alcohol consumption 
more harmful for 
patients with 
congenital heart 
disease than for other 
people? 
21.0 (19.7 to 22.3) 8.1 (7.2 to 9.0) 71.0 (69.6 to 
72.4) 
Percentage of CHD patients that give either correct, does not know, or incorrect answers 
to questions about their condition.  Table recreated from Moons, 2001. 
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DISCUSSION 
 
	 The prevalence of CHDs has been increasing over the past 4 decades.  Although 
CHD cases in aggregate have increased from 50.1 in 10,000 live births to 84.5 in 10,000 
live births over a 25-year period, most CCHD cases have not experienced a similar 
increase (Oster et al., 2013).  Less severe types of CHD such as atrioventricular septal 
defects and peripheral pulmonic stenosis account for the majority of the increased 
prevalence, likely due to better diagnostic techniques for these particular defects (Botto et 
al., 2001).  This data is consistent with other studies that have shown 2D and color-
Doppler echocardiography to increase detection of CHD (Wilson et al., 1993).  The 
number of missed diagnoses of CCHD leading to death has been decreasing over a 
similar time period, highlighting the improvement of diagnostic techniques.  SpO2 
screening with pulse oximetry may further limit the number of missed CCHD diagnoses, 
as it has been proven effective in ascertaining CCHDs in asymptomatic newborns 
(Maheshwari, 2012).  This is particularly important, because missed diagnosis of CCHD 
contributed to death in approximately 30 infants per year on average between 1989 and 
2004 in California (Chang et al., 2008). 
 Adequate and early diagnosis is of utmost importance, as CCHDs present a high 
risk of mortality in the first year of life.  CCHDs including HLHS, PA, TOF, TAPVC, 
TGA, and TA may lead to symptoms such as heart murmurs, trouble breathing, trouble 
feeding, poor weight gain, puffiness around the face and eyes, sweating, fatigue, and 
cyanosis (“Types of Congenital Heart Defects”, 2011).  1 in 4 babies born with CHD will 
require surgery during infancy, and only 75.2% of these patients with CCHDs will 
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survive their first year (“Data & Statistics”, 2015).  Figure 6 reveals that there is a 
substantial decrease in mortality risk after infancy, underscoring the importance of early 
diagnosis and intervention (Oster et al., 2013).  Prenatal diagnosis of CCHDs such as 
TGA, HLHS, and Coarctation of the Aorta using fetal echocardiography may lead to 
increased and earlier detection of CCHDs and subsequent improvements in perioperative 
outcomes (McGovern et al., 2014).  
 Although there is a high risk of mortality in the first year of life for CHD patients, 
one-year survival rates have been increasing.  The MACDP data reveals that one-year 
survival rate for patients with CCHD improved from 67.4% to 82.5% over a 25-year 
period (Oster et al., 2013).  Median age at death for CHD patients has also increased, 
while mortality has decreased steadily (Oster et al., 2013).  Children <4 year of age have 
experienced greater decreases in mortality per year and in aggregate, revealing that 
diagnostic and surgical improvements have had greater effects in infancy and early 
childhood (Boneva et al., 2001).  Prostaglandin management of CCHDs has been 
effective in maintaining a patent ductus arteriosus, allowing greater circulation of 
oxygenated blood in CCHD cases.  Prostaglandins have been especially important in 
cases involving left-side obstructions, pulmonary hypertension and cyanosis such as TGA 
and HLHS (Freedom et al., 2000).  Balloon catheterizations of valvular defects, arterial 
switch for TGA, and total bypasses of the right heart have also played roles in increasing 
survival during the first years of life (Freedom et al., 2000).  In fact, improvements in 
diagnosis and surgical interventions have led to a large population of CHD and CCHD 
patients entering adolescence and adulthood.  While diagnostics and surgical techniques 
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are still being perfected, their improvements over time have led to a population of adults 
with CHD that outnumbers the population of children with CHD. 
 Diagnostic and surgical advancements have increased survival for CHD patients, 
yet they have failed to positively affect psychosocial and QoL outcomes.  CCHDs may 
cause newborns to experience low oxygen saturations before surgical intervention, and 
many have incurred neurologic damage before corrective surgery is possible.  In addition, 
patients undergoing surgical intervention for acyanotic cardiac lesions have been proven 
to experience neurological decline from the surgery itself.  Limperopoulus et al. have 
observed such trends, reporting that more than half of CCHD patients demonstrated 
neurodevelopmental disabilities pre-surgery, and that status remained unchanged for most 
post-surgery (2000).  Strong associations have been made between oxygen saturations 
<85% and developmental delay, and while surgery may prevent subsequent hypoxic 
episodes, many newborns with cyanotic lesions have already experienced neurologic 
compromise (Limperopoulos et al., 2000). 
 Research has shown higher risks for psychological maladjustment among school-
aged CHD patients; they have been more likely than their healthy classmates to have 
autism, ADHD/ADD, learning disabilities, inattention, and hyperactivity (Jerrell et al., 
2015; Razzaghi et al., 2015; Shillingford et al., 2008).  Such disabilities have led to 
increased numbers of CHD patients requiring special education services (Riehle-
Colarusso et al., 2015; Shillingford et al., 2008).  In addition, CHD patients are more 
likely than their peers to miss 10+ days of school, further widening the developmental 
gap (Razzaghi et al., 2015).  School absences also have an adverse affect on self-reported 
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PedsQL scores, as do subsequent cardiac interventions, the need to take medications 
frequently, and noncardiac comorbidities (Knowles et al., 2014).  Early neurological 
compromise has led to learning disabilities, and ongoing medical and developmental 
issues have led to lower psychosocial, physical, and overall quality of life for CHD 
patients. 
 Qualitatively, CHD patients have reported feeling different, isolated, unsure about 
their future, and unaware of their life expectancy (Graham, 2012).  Low self-efficacy is 
an underlying theme among CHD patients, especially with respect to assuming 
responsibility for their own health care.  This can be seen specifically in how they address 
exercise.  A Belgian study has documented that a majority of CHD patients make 
sedentary lifestyle choices, as only 15% of adolescents with CHD exercise for at least 30 
minutes after school every day (Reybrouck and Mertens, 2005).  While a Taiwanese 
study argues that this is no different than the general population, the consequences may 
be greater for CHD patients; sedentary lifestyles lead to exercise intolerance, evidenced 
by suboptimal values for aerobic performance for patients with certain CHDs (Chen et 
al., 2007; Massin et al., 2007).  In addition to preventing adult onset diseases such as 
atherosclerosis, type II diabetes, and obesity, exercise may help increase oxygen 
consumption and improve functional capacity when the defect may limit normal levels.  
Furthermore, decreased sense of self-efficacy and health fears in sports have been proven 
to be more limiting than the defect symptoms themselves.  Lack of quality professional 
guidance and parental overprotection have played major roles in increasing fear and 
decreasing self-efficacy (Bar-Mor et al., 2000; Moola et al., 2008).  
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 In Portugal, interesting correlations have been made between the level of social 
support and quality of life for CHD patients.  For those with good social support, quality 
of life was higher than those with poor social support in physical, psychological, social, 
environmental, and overall categories (Areias et al., 2013).  Although the main 
determinant of quality of life seems to be the limitation on physical functioning and the 
severity of CHD, this study reveals that good social support systems may play a role in 
increasing quality of life.  CHD patients may benefit from health care providers assuming 
responsibility for putting these support systems into place, in addition to family and 
community efforts. 
 Conflicting studies have been published on quality of life for CHD patients.  
Some studies have even reported a higher QoL for CHD patients having undergone 
arterial switch for TGA than the general population (Hovels-Gurich, 2002; Latal et al., 
2009).  Most differences can be seen in parental versus self and teacher reported scores, 
as overprotection tends to be a common theme among CHD parents.  While parents may 
be more astute to their children’s condition, they have also shown signs of limiting self-
efficacy in their children.  Significant associations have been made between the severity 
of the defect and its physical limitations and quality of life, even though many studies 
present conflicting data. 
 More research on the psychosocial outcomes and quality of life for CHD patients 
is needed.  While some studies do address the outcomes for CHD patients as a whole, 
many of the studies only look at outcomes for specific cyanotic defects that require 
corrective surgery such as TOF and TGA.  The outcome data for such studies cannot be 
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expanded to make conclusions for CHD patients as a whole.  Furthermore, the fact that 
most QoL data is subjective raises questions about the conclusions one can draw, 
especially when the data is so conflicting. 
 Great advances have been made in the diagnostic and surgical management of 
CHD for patients during infancy.  The large number of studies that have been published 
on the outcomes for specific surgeries reflect the importance of medical intervention 
during the first year of life.  However, Spijkerboer et al. have shown that similar 
advances have not been as successful in the psychosocial realm; surgical management of 
CHD has not necessarily led to better psychosocial outcomes (2008).  The fact that data 
on psychosocial outcomes is both lacking and conflicting reveals a gap in the medical 
management of CHD patients as they enter adolescence and adulthood. 
 This gap in medical management is also reflected in the poor transfer rates from 
pediatric to adult care specialists for CHD patients.  In Canada, Reid et al. reported that 
less than half of CHD patients followed up at ACHD, and Mackie et al. revealed that 
nearly 2/3 of CHD patients failed to follow-up with an adult cardiologist after turning 18 
(2004; 2009).  While Reid et al. also concluded that those with more complex forms of 
CHD were more likely to transfer successfully, Mackie et al. showed that even those with 
moderate or complex CHD were at risk for loss to follow-up (2004; 2009).  Mackie’s 
research also showed a steady decline in follow-up for CHD patients starting in 
childhood.  For those with simple lesions, attrition began during infancy, while those with 
more complex lesions failed to follow-up with cardiologists during late childhood and 
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adolescence (Mackie et al., 2009).  Such a steady decline evinces a systemic problem 
with the process of transferring care. 
 A German study revealed that more than 76% of CHD patients experienced a gap 
in medical care of >5 years (Wacker et al., 2005).  This is especially disconcerting 
because of the large sample size (n>10,500).  For those who responded to a questionnaire 
(approximately 2,000/10,500), believing that they were in good health was a major 
reason for the gap in coverage (Wacker et al., 2005).  However, UK and US studies have 
revealed that those who fail to follow-up are more likely to have cardiac morbidity or 
require urgent cardiac intervention respectively (Bono and Freeman, 2005; Bono, 2005; 
Yeung, 2008).  Goosens et al. has been the only study to report successful transfer rates 
for CHD patients (2011). 
 While transfer of care is the actual moment when care is handed over from 
pediatric to adult care providers, transition is an ongoing process that involves education 
of the patient in preparation for the moment of transfer.  Mackie’s reported steady decline 
in follow-up reveals a systemic problem with this transition process.  This problem is 
further underscored by CHD patients’ lack of knowledge about their condition and future 
responsibilities.  Carizia et al. showed that many CHD patients have a poor understanding 
of their condition, the effects of substance abuse, and knowledge of the transfer process 
(2009).  Moons revealed a similar lack of knowledge among CHD patients; almost half 
did not understand the need for follow-up, while less than 1/3 could identify symptoms of 
deteriorating heart condition (2001).  Furthermore, they had a very poor understanding of 
their risks for endocarditis.  For those with a greater understanding of their defect, they 
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were more likely to understand the transition process and showed traits of self-efficacy 
(conversed with their providers directly) (Moons, 2001). 
 For some diseases such as Cystic Fibrosis, formal transition programs have been 
effective in increasing the probability of successful transfer to adult care.  Okumura et al. 
discovered that the administration of a formal transition process led to increased 
discussion of transition between care providers and patients (35% to 73%), increased 
self-efficacy among patients, and a reduced percentage of transfer occurring due to 
hospitalization for complications (2014).  According to Okumura et al., the concept of 
shared responsibility was paramount, mainly focusing on three relationships: 
“intrapersonal (within patient and provider), interpersonal (among providers and between 
providers and patients), and within the community (clinic or hospitals)” (2014).  These 
themes of coordination, shared responsibility and communication are echoed by the 
AHA’s four essentials for successful transition: “comprehensive care that is coordinated 
and managed through a medical home…, access to healthcare financing, education of 
adult providers in managing chronic conditions previously limited to the pediatric 
population, [and] ongoing, coordinated communication between patients, families, and 
pediatric and adult healthcare providers to facilitate transition and transfer” (Graham, 
2012).  While transition management of CHD patients has been insufficient in the past, 
implementing formal transition programs that focus on these ideals may allow CHD 
patients to experience similar improvements as Cystic Fibrosis patients. 
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Conclusion. 
Affecting nearly 1% of all births, Congenital Heart Defects continue to be a major health 
concern in the United States.  As better diagnostic techniques emerge, the observed 
prevalence of CHDs will continue to rise and add to the 1 million children and 1 million 
adults already living with CHD.  While most improvements in the medical management 
of CHD have focused on the early stages of life, the rising number of aging CHD patients 
presents an alarming need for innovations in the management of CHD during adolescence 
and adulthood.  Specifically, CHD patients may benefit from innovative psychosocial 
research and structured transition programs. 
 Improvements in diagnostic and surgical techniques have led to better 1-year and 
18-year survival rates for CHD patients.  However, as patients enter adolescence and 
adulthood, they are faced with many psychosocial issues that surgical innovations have 
failed to address.  CHD patients report feeling isolated and different than their healthy 
peers, while they also experience an increased risk for developmental disabilities, 
learning disabilities, inattention, hyperactivity, autism, and depression.  Transition 
programs that address these psychosocial issues may increase QoL for the patient. 
  Transition management of CHD should also center on increasing knowledge, 
understanding, and self-efficacy in the patient, while also providing a coordinated 
“medical home.”  In the past, proper understanding of CHD, communication, and 
assuming responsibility for one’s care have been common associations with increased 
transfer to adult care specialists.  Integrating these themes into formal transition programs 
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that are flexible, individualized, and coordinated may lead to better QoL, higher transfer 
rates, and better psychosocial and medical outcomes.	  
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